Program
sodium zirconium cyclosilicate
Also written as “Sodium Zirconium Cyclosilicate”, “Sodium Zirconium Cyclosilicate (SZC)” and “Sodium zirconium cyclosilicate”.
Its studies are mostly in Hyperkalemia · Renal Insufficiency, Chronic · Heart Failure, led by AstraZeneca.
Drug pageSodium zirconium cyclosilicate: every studyAll 30 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AstraZeneca | 202 open or running | phase 4since Dec 16, 2020 | Mar 12, 2014 | Oct 30, 2027phase 4 · NCT07944378 |
Also a collaborator on its studies: Parexel.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 6 studies since Mar 12, 2014.
- Sep 26, 2017Phase 3 study in HyperkalemiaNCT03303521 · 196 enrolled · United States, Japan, Russian Federation and more
- Oct 23, 2017Phase 2 study in HyperkalemiaNCT03337477 · 70 enrolled · United States, Denmark, Italy and more
- Mar 29, 2018Phase 2 study in Heart FailureNCT03532009 · 182 enrolled · United States, Brazil, Bulgaria and more
- Apr 16, 2018Phase 3 study in HyperkalemiaNCT03528681 · 270 enrolled · China, India
- Nov 22, 2018Phase 3 study in HyperkalemiaNCT03813407 · 140 planned · United States, Brazil, Canada and more
- Jan 2, 2020Phase 3 study in HyperkalemiaNCT04217590 · 134 enrolled · China
- Dec 16, 2020Phase 4 study in HyperkalemiaNCT04676646 · 366 enrolled · United States, Brazil, Canada and more
- Dec 22, 2020Phase 3 study in HyperkalemiaNCT04727528 · 39 enrolled · United States, Puerto Rico
- Mar 5, 2021Phase 1 study in HyperkalemiaNCT04788641 · 62 enrolled · Germany
- Apr 8, 2021Phase 3 study in HyperkalemiaNCT04847232 · 2,690 enrolled · United States, Argentina, Austria and more
- Jun 16, 2021Phase 4 study in HyperkalemiaNCT04997161 · 3 enrolled · United States
- Sep 1, 2021Phase 3 study in Renal Insufficiency, ChronicNCT05056727 · 1,112 enrolled · United States, Argentina, Brazil and more
- Feb 23, 2022Phase 4 study in HyperkalemiaNCT05347693 · 186 enrolled · Belgium, France, Italy and more
- Nov 3, 2026Phase 4 study in HyperkalemiaNCT07944378 · 120 planned · India
Ahead
- Oct 30, 2027Primary completion: phase 4 study in HyperkalemiaNCT07944378
- Feb 21, 2030Primary completion: phase 3 study in HyperkalemiaNCT03813407
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 20 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07944378Hyperkalemia · India | 4 | Recruiting | Oct 30, 2027 | 120 |
| NCT05347693Hyperkalemia · Belgium, France, Italy and more | 4 | Completed | Dec 10, 2024 | 186 |
| NCT05056727Renal Insufficiency, Chronic · United States, Argentina, Brazil and more | 3 | Terminated | Feb 7, 2024 | 1,112 |
| NCT04997161Hyperkalemia · United States | 4 | Terminated | Nov 17, 2021 | 3 |
| NCT04847232Hyperkalemia · United States, Argentina, Austria and more | 3 | Terminated | Mar 7, 2024 | 2,690 |
| NCT04788641Hyperkalemia · Germany | 1 | Completed | Sep 16, 2021 | 62 |
| NCT04727528Hyperkalemia · United States, Puerto Rico | 3 | Terminated | Sep 14, 2022 | 39 |
| NCT04676646Hyperkalemia · United States, Brazil, Canada and more | 4 | Completed | Jul 15, 2024 | 366 |
| NCT04217590Hyperkalemia · China | 3 | Completed | Jan 3, 2022 | 134 |
| NCT03813407Hyperkalemia · United States, Brazil, Canada and more | 3 | Recruiting | Feb 21, 2030 | 140 |
| NCT03528681Hyperkalemia · China, India | 3 | Completed | Sep 15, 2022 | 270 |
| NCT03532009Heart Failure · United States, Brazil, Bulgaria and more | 2 | Terminated | May 22, 2020 | 182 |
| NCT03337477Hyperkalemia · United States, Denmark, Italy and more | 2 | Completed | Dec 21, 2018 | 70 |
| NCT03303521Hyperkalemia · United States, Japan, Russian Federation and more | 3 | Completed | Nov 7, 2018 | 196 |
| NCT03283267Hyperkalemia · Hong Kong | 1 | Completed | Nov 23, 2017 | 22 |
| NCT03127644Hyperkalemia · Japan | 3 | Completed | Feb 23, 2018 | 103 |
| NCT02875834Hyperkalemia · Japan, Korea, Republic of, Russian Federation and more | 3 | Completed | Feb 14, 2018 | 267 |
| NCT02163499Hyperkalemia · United States, Australia, Germany and more | 3 | Completed | Nov 30, 2016 | 751 |
| NCT02107092Hyperkalemia · United States, Australia, South Africa | 3 | Completed | Jul 31, 2015 | 123 |
| NCT02088073Hyperkalemia · United States, Australia, South Africa | 3 | Completed | Aug 31, 2014 | 258 |
How it is read
Names in the registry
- “Sodium Zirconium Cyclosilicate”, 5 entries
- “Sodium Zirconium Cyclosilicate (SZC)”, 4 entries
- “Sodium zirconium cyclosilicate”, 3 entries
- “Sodium Zirconium Cyclosilicate (ZS) 10g”, 3 entries
- “Sodium Zirconium Cyclosilicate (ZS) 5g”, 2 entries
Conditions, from the studies’ own filings
- Hyperkalemia, 18 studies
- Renal Insufficiency, Chronic, 1 study
- Heart Failure, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.